Sujet(s)
Adénomes , Glandes duodénales , Tumeurs du duodénum , Hémorragie gastro-intestinale , Humains , Adénomes/chirurgie , Adénomes/complications , Ligature/méthodes , Glandes duodénales/chirurgie , Glandes duodénales/anatomopathologie , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/chirurgie , Tumeurs du duodénum/chirurgie , Tumeurs du duodénum/complications , Mâle , Femelle , Adulte d'âge moyenSujet(s)
Mucosectomie endoscopique , Techniques de suture , Humains , Mucosectomie endoscopique/effets indésirables , Mucosectomie endoscopique/méthodes , Mucosectomie endoscopique/instrumentation , Techniques de suture/instrumentation , Techniques de suture/effets indésirables , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/chirurgie , Rectum/chirurgie , Tumeurs du rectum/chirurgie , Mâle , Femelle , Sujet âgéSujet(s)
Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Hypersplénisme , Laparoscopie , Cirrhose du foie , Veine porte , Splénectomie , Humains , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/étiologie , Laparoscopie/méthodes , Cirrhose du foie/complications , Cirrhose du foie/chirurgie , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Splénectomie/méthodes , Hypersplénisme/chirurgie , Hypersplénisme/étiologie , Veine porte/chirurgie , Veine azygos/chirurgieRÉSUMÉ
The combination of endoscopic ultrasound with endoscopic treatment of type 1 gastric variceal hemorrhage may improve the robustness and generalizability of the findings in future studies. Moreover, the esophageal varices should also be included in the evaluation of treatment efficacy in subsequent studies to reach a more convincing conclusion.
Sujet(s)
Endosonographie , Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Adhésifs tissulaires , Varices oesophagiennes et gastriques/thérapie , Varices oesophagiennes et gastriques/étiologie , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/diagnostic , Humains , Ligature/méthodes , Résultat thérapeutique , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/thérapie , Hémorragie gastro-intestinale/chirurgie , Adhésifs tissulaires/administration et posologie , Endosonographie/méthodes , Injections , Hémostase endoscopique/méthodes , Endoscopie gastrointestinale/méthodesRÉSUMÉ
Ectopic varices account for 5% of variceal bleedings and occur outside the gastro-esophageal region. This review evaluates the efficacy of transjugular intrahepatic portosystemic shunt (TIPS) for ectopic variceal management. A comprehensive search through PubMed, Scopus, Web of Science, and Embase was conducted until January 16, 2023, using relevant keywords. Case reports and case series with fewer than 10 patients on TIPS for ectopic variceal management were included. The quality assessment followed the Joanna Briggs Institute checklist for case reports. This systematic review evaluated 43 studies involving 50 patients with ectopic varices undergoing TIPS. Patients had a mean age of 54.3 years, half were female, and two were pregnant. Alcoholic liver disease (48%) and hepatitis C infection (26%) were common causes of portal hypertension. Ascites and splenomegaly were reported in 32% and 28% of the patients, respectively. Rectal, oral, and stomal variceal bleeding accounted for 62%, 16%, and 22% of the patients, respectively. Ectopic varices were mainly located in the duodenum (28%) and rectum (26%) regions. Complications affected 42% of the patients, re-bleeding in eleven and hepatic encephalopathy in seven. The follow-up lasted 12 months on average, and finally, 5 received a liver transplant. Mortality post-TIPS was 18%. Despite complications and a notable mortality rate, favorable outcomes were observed in almost half of the patients with ectopic variceal bleeding managed with TIPS. Further research is warranted to refine strategies and improve patient outcomes.
Sujet(s)
Hémorragie gastro-intestinale , Anastomose portosystémique intrahépatique par voie transjugulaire , Humains , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/complications , Hypertension portale/complications , Hypertension portale/chirurgie , FemelleRÉSUMÉ
Transjugular intrahepatic portosystemic shunt (TIPS) is a medical procedure that has been used to manage variceal bleeding and ascites in patients with cirrhosis. It can prevent further decompensation and improve the survival of high-risk decompensated patients. Recent research indicates that TIPS could increase the possibility of recompensation of decompensated cirrhosis when it is combined with adequate suppression of the causative factor of liver disease. However, the results of the studies have been based on retrospective analysis, and further validation is required by conducting randomized controlled studies. In this context, we highlight the limitations of the current studies and emphasize the issues that must be addressed before TIPS can be recommended as a potential recompensating tool.
Sujet(s)
Ascites , Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Cirrhose du foie , Anastomose portosystémique intrahépatique par voie transjugulaire , Anastomose portosystémique intrahépatique par voie transjugulaire/méthodes , Anastomose portosystémique intrahépatique par voie transjugulaire/effets indésirables , Humains , Cirrhose du foie/complications , Cirrhose du foie/chirurgie , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/étiologie , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/prévention et contrôle , Ascites/étiologie , Ascites/chirurgie , Résultat thérapeutique , Hypertension portale/chirurgie , Hypertension portale/étiologieRÉSUMÉ
BACKGROUND: This study investigated the value of prognostic scores to predict 90-day, 1-, 3- and 5-year survival after salvage TIPS (sTIPS) in patients with exsanguinating variceal bleeding who failed endoscopic intervention. METHODS: The Model for End-Stage Liver Disease (MELD), Model for End-Stage Liver Disease Sodium (MELDNa), Acute Physiology and Chronic Health Evaluation II (APACHE II) and Child-Pugh (C-P) grades and scores were calculated using Kaplan-Meier curves and Cox proportional hazards models in sTIPS patients treated between August 1991 and November 2020. RESULTS: Thirty-four patients (29 men, 5 women), mean age 52 years, SD ± 11.6 underwent sTIPS which controlled bleeding in 32 (94%) patients. Ten (29.4%) patients died in hospital at a median of 4.8 (range 1-10) days. On bivariate analysis, C-P score ≥ 10 (p = 0.017), high C-P grade (p = 0.048), MELD ≥ 15 (p = 0.010), MELD-Na score ≥ 22 (p < 0.001) and APACHE II score ≥ 15 (p < 0.001) predicted 90-day mortality. Individual clinical characteristics associated with 90-day mortality were grade 3 ascites (p = 0.029), > 10 units of blood transfused (p = 0.004), balloon tube placement (p < 0.001), endotracheal intubation (< 0.001) and inotrope support (p < 0.001). The overall 90-day, 1-, 3- and 5-year survival rates were 67.6%, 55.9%, 26.5% and 20.6% respectively. Nine patients (26.5%) were alive at a median of two years (range 1-18 years) post-TIPS. Patients with C-P grade A, C-P score < 10, MELD score < 15, MELD-Na score < 22 and APACHE II score < 15 had significantly better 90-day, 1-, 3- and 5-year survival rates. CONCLUSION: Although sTIPS controlled variceal bleeding in 94% of patients after failed endoscopic therapy, in-hospital mortality was 29% and less than one quarter were alive after five years. The selected cut-off values for the nominated scoring systems accurately predicted 90-day mortality and long-term survival.
Sujet(s)
Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Anastomose portosystémique intrahépatique par voie transjugulaire , Humains , Mâle , Femelle , Adulte d'âge moyen , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/mortalité , Hémorragie gastro-intestinale/étiologie , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/mortalité , Varices oesophagiennes et gastriques/complications , Pronostic , Anastomose portosystémique intrahépatique par voie transjugulaire/méthodes , Thérapie de rattrapage/méthodes , Études rétrospectives , Adulte , Taux de survie , Indice de gravité de la maladie , Indice APACHERÉSUMÉ
BACKGROUND Severe anemia caused by hemorrhoidal hematochezia is typically treated preoperatively with reference to severe anemia treatment strategies from other etiologies. This retrospective cohort study included 128 patients with hemorrhoidal severe anemia admitted to 3 hospitals from September 1, 2018, to August 1, 2023, and aimed to evaluate preoperative blood transfusion requirements. MATERIAL AND METHODS Of 5120 patients with hemorrhoids, 128 (2.25%; male/female: 72/56) experienced hemorrhoidal severe anemia, transfusion, and Milligan-Morgan surgery. Patients were categorized into 2 groups based on their preoperative hemoglobin (PHB) levels after transfusion: PHB ≥70 g/L as the liberal-transfusion group (LG), and PHB <70 as the restrictive-threshold group (RG). The general condition, bleeding duration, hemoglobin level on admission, transfusion volume, length of stay, immune transfusion reaction, surgical duration, and hospitalization cost were compared between the 2 groups. RESULTS Patients with severe anemia (age: 41.07±14.76) tended to be younger than those with common hemorrhoids (age: 49.431±15.59 years). The LG had a significantly higher transfusion volume (4.77±2.22 units), frequency of immune transfusion reactions (1.22±0.58), and hospitalization costs (16.69±3.31 thousand yuan) than the RG, which had a transfusion volume of 3.77±2.09 units, frequency of immune transfusion reactions of 0.44±0.51, and hospitalization costs of 15.00±3.06 thousand yuan. Surgical duration in the LG (25.69±14.71 min) was significantly lower than that of the RG (35.24±18.72 min). CONCLUSIONS Patients with hemorrhoids with severe anemia might require a lower preoperative transfusion threshold than the currently recognized threshold, with an undifferentiated treatment effect and additional benefits.
Sujet(s)
Anémie , Transfusion sanguine , Hémorroïdes , Soins préopératoires , Humains , Mâle , Femelle , Études rétrospectives , Anémie/thérapie , Anémie/étiologie , Transfusion sanguine/méthodes , Adulte d'âge moyen , Adulte , Hémorroïdes/chirurgie , Hémorroïdes/complications , Soins préopératoires/méthodes , Hémoglobines/analyse , Hémoglobines/métabolisme , Durée du séjour , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/thérapie , Sujet âgéRÉSUMÉ
Endoscopic resection techniques have evolved over time, allowing effective and safe resection of the majority of pre-malignant and early cancerous lesions in the gastrointestinal tract. Bleeding is one of the most commonly encountered complications during endoscopic resection, which can interfere with the procedure and result in serious adverse events. Intraprocedural bleeding is relatively common during endoscopic resection and, in most cases, is a mild and self-limiting event. However, it can interfere with the completion of the resection and may result in negative patient-related outcomes in severe cases, including the need for hospitalization and blood transfusion as well as the requirement for radiological or surgical interventions. Appropriate management of intraprocedural bleeding can improve the safety and efficacy of endoscopic resection, and it can be readily achieved with the use of several endoscopic hemostatic tools. In this review, we discuss the recent advances in the approach to intraprocedural bleeding complicating endoscopic resection, with a focus on the various endoscopic hemostatic tools available to manage such events safely and effectively.
Sujet(s)
Hémorragie gastro-intestinale , Hémostase endoscopique , Humains , Hémostase endoscopique/méthodes , Hémostase endoscopique/effets indésirables , Hémostase endoscopique/instrumentation , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Résultat thérapeutique , Endoscopie gastrointestinale/effets indésirables , Endoscopie gastrointestinale/méthodes , Perte sanguine peropératoire/prévention et contrôle , Hémostatiques/administration et posologie , Hémostatiques/usage thérapeutiqueSujet(s)
Varices oesophagiennes et gastriques , Hémostase endoscopique , Varices , Humains , Hémorragie gastro-intestinale/imagerie diagnostique , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/chirurgie , Varices oesophagiennes et gastriques/complications , Varices oesophagiennes et gastriques/imagerie diagnostique , Varices oesophagiennes et gastriques/chirurgie , Varices/complications , Varices/imagerie diagnostique , Varices/chirurgie , Échographie interventionnelleRÉSUMÉ
INTRODUCTION: Hematomas are a rare cause of intestinal obstruction. Subcutaneous heparin can bring about direct punctures on small bowel loops, potentially leading to traumatic hematoma and intestinal obstruction. CASE REPORTS: We present three cases of pediatric patients with clinical signs of intestinal obstruction treated with subcutaneous heparin. Two cases had increased acute-phase reactants and radiological signs of intestinal suffering, so surgical treatment was decided upon, with intramural hematoma emerging as an intraoperative finding. The third case was conservatively managed with anticoagulant discontinuation and gut rest, since the patient had an adequate general condition and no findings compatible with ischemia or necrosis were noted in the complementary tests. DISCUSSION: The administration of subcutaneous heparin may cause intestinal wall hematomas due to its anticoagulating effect and to the risk of inadvertent punctures on small bowel loops.
INTRODUCCION: Los hematomas son una causa poco frecuente de obstrucción intestinal. La heparina subcutánea tiene riesgo de producir la punción directa de un asa intestinal, provocando un hematoma traumático que genere una obstrucción intestinal. CASOS CLINICOS: Se describen tres casos de pacientes pediátricos con clínica de obstrucción intestinal en tratamiento con heparina subcutánea. Dos casos presentaron elevación de reactantes de fase aguda y signos radiológicos de sufrimiento intestinal por lo que se optó por tratamiento quirúrgico, con el hallazgo intraoperatorio de hematoma intramural. El tercer caso fue manejado de manera conservadora con supresión de la anticoagulación y reposo intestinal, dado el adecuado estado general y ausencia de hallazgos compatibles con isquemia o necrosis en las pruebas complementarias. COMENTARIOS: La administración de heparina subcutánea puede provocar la aparición de hematomas de pared intestinal, tanto por su efecto anticoagulante, como por el riesgo de punción inadvertida de un asa intestinal.
Sujet(s)
Héparine bas poids moléculaire , Occlusion intestinale , Humains , Enfant , Héparine bas poids moléculaire/effets indésirables , Anticoagulants/effets indésirables , Occlusion intestinale/induit chimiquement , Occlusion intestinale/chirurgie , Hématome/induit chimiquement , Hématome/complications , Hématome/chirurgie , Hémorragie gastro-intestinale/chirurgie , Héparine/effets indésirablesRÉSUMÉ
RATIONALE: The bleeding of Dieulafoy lesion predominantly involves the proximal stomach and leads to severe gastrointestinal bleeding. However, these lesions have also been reported in the whole gastrointestinal tract. Bleeding of Dieulafoy lesions at the anastomosis was seldomly reported and was very easy to be ignored clinically. PATIENT CONCERNS: We describe a 72-year-old woman with a past history of surgery for rectal carcinoma hospitalized with chief complaint of massive rectal bleeding. No gross bleeding lesion was found during the first emergency colonoscopy. Despite multiple blood transfusions, her hemoglobin rapidly dropped to 5.8 g/dL. DIAGNOSIS: She was diagnosed with Dieulafoy lesion at the colorectal anastomosis during the second emergency colonoscopy. INTERVENTIONS: Primary hemostasis was achieved by endoscopic hemostatic clipping. However, she experienced another large volume hematochezia 3 days later, and then received another endoscopic hemostatic clipping. She was improved and discharged. However, this patient underwent hematochezia again 1 month later. Bleeding was arrested successfully after the over-the-scope clip (OTSC) was placed during the fourth emergency colonoscopy. OUTCOMES: This patient underwent 4 endoscopic examinations and treatments during 2 hospitalizations. The lesion was overlooked during the first emergency colonoscopy. The second and third endoscopes revealed Dieulafoy lesion at the colorectal anastomosis and performed endoscopic hemostatic clippings, but delayed rebleeding occurred. The bleeding was stopped after the fourth emergency colonoscopy using OTSC. There was no further rebleeding during hospitalization and after 2-year of follow-up. LESSONS: As far as we know, there is no reported case of lower gastrointestinal bleeding caused by Dieulafoy lesion at the colorectal anastomosis, OTSC is a safe and effective rescue treatment for Dieulafoy lesions.
Sujet(s)
Tumeurs colorectales , Hémostase endoscopique , Hémostatiques , Maladies vasculaires , Humains , Femelle , Sujet âgé , Hémostase endoscopique/effets indésirables , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/chirurgie , Maladies vasculaires/complications , Anastomose chirurgicale/effets indésirables , Tumeurs colorectales/thérapieSujet(s)
Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Hypertension portale , Laparoscopie , Splénectomie , Humains , Hypertension portale/chirurgie , Hypertension portale/complications , Splénectomie/méthodes , Laparoscopie/méthodes , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Varices oesophagiennes et gastriques/chirurgie , Veine azygos/chirurgie , Veine porte/chirurgie , Mâle , Femelle , Adulte d'âge moyen , Résultat thérapeutiqueRÉSUMÉ
PURPOSE OF REVIEW: This review is focused on diagnostic and management strategies for colonic diverticular bleeding (CDB). It aims to present the current state of the field, highlighting the available techniques, and emphasizing findings that influence the choice of therapy. RECENT FINDINGS: Recent guidelines recommend nonurgent colonoscopy (>24âh) for CDB. However, factors such as a shock index ≥1, which may warrant an urgent colonoscopy, remain under investigation.The standard approach to detecting the source of CDB requires a water-jet scope equipped with a cap. Innovative diagnostic techniques, such as the long-cap and tapered-cap, have proven effective in identifying stigmata of recent hemorrhage (SRH). Furthermore, the water or gel immersion methods may aid in managing massive hemorrhage by improving the visualization and stabilization of the bleeding site for subsequent intervention. Innovations in endoscopic hemostasis have significantly improved the management of CDB. New therapeutic methods such as endoscopic band ligation and direct clipping have substantially diminished the incidence of recurrent bleeding. Recent reports also have demonstrated the efficacy of cutting-edge techniques such as over-the-scope clips, which have significantly improved outcomes in complex cases that have historically necessitated surgical intervention. SUMMARY: Currently available endoscopic diagnostic and hemostatic methods for CDB have evolved with improved outcomes. Further research is necessary to refine the criteria for urgent colonoscopy and to confirm the effectiveness of new endoscopic hemostasis techniques.
Sujet(s)
Coloscopie , Hémorragie gastro-intestinale , Hémostase endoscopique , Humains , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/diagnostic , Hémorragie gastro-intestinale/thérapie , Coloscopie/méthodes , Hémostase endoscopique/méthodes , Diverticule du côlon/complications , Diverticule du côlon/chirurgieRÉSUMÉ
Polyglycolic acid sheets and fibrin glue are routinely used in surgical procedures. Their usefulness in gastrointestinal endoscopy is mainly to prevent complications (bleeding, delayed perforation, stenosis, etc.) associated with procedures such as endoscopic submucosal dissection and endoscopic mucosal resection, with most reports on iatrogenic and secondary conditions. However, there are few reports on primary gastrointestinal diseases. Herein, we report three cases of gastrointestinal bleeding that were successfully treated with endoscopic hemostasis by sealing the lesions with polyglycolic acid sheets and fibrin glue. Case 1 was of an 83-year-old woman with a rare duodenal perforation that was treated with omental plugging who experienced subsequent bleeding from the greater omentum. Case 2 was of a 73-year-old woman with an acute hemorrhagic rectal ulcer that was difficult to treat even after performing standard endoscopic hemostasis techniques; however, surgery was avoided by sealing. Case 3 was that of an 89-year-old woman with a stercoral ulcer, treated curatively using a combination of sealing and argon plasma coagulation right from presentation based on the lessons learned from Cases 1 and 2. Endoscopic hemostasis using a polyglycolic acid sheet and fibrin glue may be a new treatment option for gastrointestinal bleeding particularly in refractory or rare causes.
Sujet(s)
Colle de fibrine , Hémorragie gastro-intestinale , Hémostase endoscopique , Acide polyglycolique , Humains , Femelle , Colle de fibrine/usage thérapeutique , Sujet âgé , Acide polyglycolique/usage thérapeutique , Sujet âgé de 80 ans ou plus , Hémorragie gastro-intestinale/chirurgie , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/thérapie , Hémostase endoscopique/méthodes , Adhésifs tissulaires/usage thérapeutique , Maladies du rectum/chirurgieRÉSUMÉ
Data on emergency endoscopic treatment following endotracheal intubation in patients with esophagogastric variceal bleeding (EGVB) remain limited. This retrospective study aimed to explore the efficacy and risk factors of bedside emergency endoscopic treatment following endotracheal intubation in severe EGVB patients admitted in Intensive Care Unit. A total of 165 EGVB patients were enrolled and allocated to training and validation sets in a randomly stratified manner. Univariate and multivariate logistic regression analyses were used to identify independent risk factors to construct nomograms for predicting the prognosis related to endoscopic hemostasis failure rate and 6-week mortality. In result, white blood cell counts (p = 0.03), Child-Turcotte-Pugh (CTP) score (p = 0.001) and comorbid shock (p = 0.005) were selected as independent clinical predictors of endoscopic hemostasis failure. High CTP score (p = 0.003) and the presence of gastric varices (p = 0.009) were related to early rebleeding after emergency endoscopic treatment. Furthermore, the 6-week mortality was significantly associated with MELD scores (p = 0.002), the presence of hepatic encephalopathy (p = 0.045) and postoperative rebleeding (p < 0.001). Finally, we developed practical nomograms to discern the risk of the emergency endoscopic hemostasis failure and 6-week mortality for EGVB patients. In conclusion, our study may help identify severe EGVB patients with higher hemostasis failure rate or 6-week mortality for earlier implementation of salvage treatments.
Sujet(s)
Varices oesophagiennes et gastriques , Hémorragie gastro-intestinale , Intubation trachéale , Cirrhose du foie , Nomogrammes , Humains , Varices oesophagiennes et gastriques/chirurgie , Varices oesophagiennes et gastriques/étiologie , Varices oesophagiennes et gastriques/complications , Varices oesophagiennes et gastriques/thérapie , Mâle , Femelle , Adulte d'âge moyen , Hémorragie gastro-intestinale/étiologie , Hémorragie gastro-intestinale/thérapie , Hémorragie gastro-intestinale/mortalité , Hémorragie gastro-intestinale/chirurgie , Facteurs de risque , Cirrhose du foie/complications , Intubation trachéale/effets indésirables , Études rétrospectives , Sujet âgé , Hémostase endoscopique/méthodes , Pronostic , AdulteRÉSUMÉ
Inflammatory bowel disease (IBD) patients are at risk for undergoing emergency surgery for fulminant disease, toxic megacolon, bowel perforation, intestinal obstruction, or uncontrolled gastrointestinal hemorrhage. Unfortunately, medical advancements have failed to significantly decrease rates of emergency surgery for IBD. It is therefore important for all acute care and colorectal surgeons to understand the unique considerations owed to this often-challenging patient population.